We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
-5.67%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$15.3B
AUM Growth
-$1.2B
Cap. Flow
+$102M
Cap. Flow %
0.67%
Top 10 Hldgs %
32.45%
Holding
1,302
New
280
Increased
463
Reduced
337
Closed
213

Top Buys

Rank Stock Value
1
CP icon
Canadian Pacific Kansas City
CP
+$77.5M
2
TSM icon
TSMC
TSM
+$73.8M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$60.9M
4
CNI icon
Canadian National Railway
CNI
+$56.1M
5
RBA icon
RB Global
RBA
+$41.5M

Top Sells

Rank Stock Value
1
BNS icon
Scotiabank
BNS
+$79.6M
2
SU icon
Suncor Energy
SU
+$62.4M
3
BCE icon
BCE
BCE
+$51.4M
4
BMO icon
Bank of Montreal
BMO
+$46.8M
5
AZN icon
AstraZeneca
AZN
+$38.4M

Sector Composition

Rank Sector Weight
1 Financials 26.03%
2 Industrials 15.28%
3 Energy 13.03%
4 Technology 11.16%
5 Materials 8.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LITS
1051
Lite Strategy Inc
LITS
$30.4M
$74K ﹤0.01%
9,515
+5,689
+149% +$58.7K
CUE icon
1052
Cue Biopharma
CUE
$121M
$73K ﹤0.01%
+1,089
New +$93.7K
MFGP
1053
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
$69K ﹤0.01%
12,082
-2,882
-19% -$12.5K
GSIT icon
1054
GSI Technology
GSIT
$260M
$68K ﹤0.01%
24,010
+858
+4% +$2.98K
LIND icon
1055
Lindblad Expeditions
LIND
$2.25B
$68K ﹤0.01%
+10,080
New +$87.8K
UBX
1056
DELISTED
Unity Biotechnology
UBX
$64K ﹤0.01%
+16,204
New +$102K
EHTH icon
1057
eHealth
EHTH
$39.1M
$63K ﹤0.01%
+16,008
New +$112K
ENIC icon
1058
Enel Chile
ENIC
$6B
$62K ﹤0.01%
+45,033
New +$66.9K
UGP icon
1059
Ultrapar
UGP
$6.41B
$62K ﹤0.01%
+28,373
New +$71.2K
CARM
1060
DELISTED
Carisma Therapeutics
CARM
$61K ﹤0.01%
+7,138
New +$97.2K
FBIO icon
1061
Fortress Biotech
FBIO
$92.7M
$61K ﹤0.01%
4,720
+977
+26% +$14.6K
INFI
1062
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$61K ﹤0.01%
+51,580
New +$55.6K
ASUR icon
1063
Asure Software
ASUR
$241M
$59K ﹤0.01%
+10,304
New +$56.3K
ILLM
1064
DELISTED
illumin Holdings Inc. Common Shares
ILLM
$55K ﹤0.01%
31,800
+4,000
+14% +$9.34K
FARM
1065
DELISTED
Farmer Brothers
FARM
$54K ﹤0.01%
11,492
-1,575
-12% -$8.12K
SFE
1066
DELISTED
Safeguard Scientifics, Inc.
SFE
$50K ﹤0.01%
13,338
-2,293
-15% -$9.21K
INO icon
1067
Inovio Pharmaceuticals
INO
$93M
$49K ﹤0.01%
+2,345
New +$60K
YRD
1068
Yiren Digital
YRD
$105M
$45K ﹤0.01%
41,716
-5,859
-12% -$7.36K
LRMR icon
1069
Larimar Therapeutics
LRMR
$443M
$42K ﹤0.01%
+13,065
New +$32.7K
XFOR icon
1070
X4 Pharmaceuticals
XFOR
$433M
$39K ﹤0.01%
+769
New +$26.6K
SUP
1071
DELISTED
Superior Industries International
SUP
$35K ﹤0.01%
+11,754
New +$51.9K
NKTR icon
1072
Nektar Therapeutics
NKTR
$2.6B
$34K ﹤0.01%
714
-1,808
-72% -$108K
HOOK
1073
DELISTED
HOOKIPA Pharma
HOOK
$30K ﹤0.01%
+2,210
New +$33.9K
ADV icon
1074
Advantage Solutions
ADV
$420M
$28K ﹤0.01%
+525
New +$48.4K
INSG icon
1075
Inseego
INSG
$80M
$27K ﹤0.01%
+1,297
New +$31.3K
41 42
43
44 45

Similar funds

State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
PEAK6
PEAK6 Chicago, Illinois $42.6B AUM 66.24% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
Newport Trust Company
Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s Q3 2022 Portfolio in Review

As of Q3 2022, Connor, Clark & Lunn Investment Management (CC&L) held 1,302 positions worth $15.3B, down 7.3% from $16.5B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L)'s Q3 2022 filing shows 280 new, 463 increased, 337 reduced and 213 closed positions. Its largest new stake was VICI Properties: 544,471 shares worth $16.3M. The largest sale was Scotiabank, an estimated $79.6M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 28% a quarter earlier, followed by Industrials and Energy.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q3 2022 buy was VICI Properties: 544,471 shares worth $16.3M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Canadian Pacific Kansas City in Q3 2022, an estimated $77.5M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q3 2022 reduction was Scotiabank, cutting an estimated $79.6M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited United Airlines in Q3 2022, selling an estimated $30.6M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 32% of its $15.3B portfolio in Q3 2022.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 280 new positions and closed 213 in Q3 2022.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value fell 7.3% quarter-over-quarter to $15.3B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2022, filed 10 Nov 2022.